Ella said, ‘We have partnered with the Indian Council of Medical Research (ICMR) for the Kovid-19 vaccine. Phase III trial of this vaccine has started. He said that India Biotech is the only vaccine company in the world which has a biosafety level-3 (BSL3) production facility. Last month, the company said it had successfully completed an interim analysis of the first and second phase trials and was about to begin the third phase trial on 26,000 partners.
Phase III trials of Bharat Biotech’s Kovid-19 vaccine Kovaxin have begun. Krishna Ella, Chairman and Managing Director of the company gave this information on Monday. Addressing an event organized by the Indian School of Business through video conference, Ella said that the company is working on another vaccine for Kovid-19. It will be in the form of a drop through the nose. This vaccine will be ready by next year.